Abstract
A series of 1-[(sub)]-6-fluoro-3- [(sub)]-1, 3, 4-oxadiazol-2-yl-7-piperazino-1, 4-dihydro 4-quinolinones were synthesized by the reaction between ciprofloxacin and norfloxacin with an appropriate acid hydrazide in phosphorous oxychloride. All newly synthesized compounds were evaluated for their antiproliferative activities against human lung tumor cell lines (A 549). Fluoroquinolone with oxadiazole (Q 2 ) 1-cyclopropyl-6-fluoro-3- [5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]-7-piperazino-1, 4-dihydro-4-quinolinone was found to be the most active compound in vitro with a half-maximal inhibitory concentration (IC50) of 9.0 μg/mL.
Similar content being viewed by others
References
Chu DTW, Hallas R, Clement JJ, Alder J, McDonald E, Plattner JJ (1992) Synthesis and antitumor activities of quinolone antiplastic agents. Drugs Exp Clin Res 18:275–282
Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89(2):271–277
Evans VG (1993) Multiple pathways to apoptosis. Cell Boil Int 17:461–476
Gillespie SH, Gosling RD, Uiso L, Sam NE, Kanduma EG, McHugh TD (2005) Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. J Antimicrob Chemother 56(2):344–348
Kamal A (2005) Synthesis and biological activity of fluoroquinolone-pyrrolo[2,1-c][1,4]benzodiazepine conjugates. Bioorg Med Chem 13(6):2021–2029
Kawahara S (2001) In vitro antimycobacterial activities of a new quinolone, balofloxacin. Kekkaku 76(1):29–31
Kim MY, Duan W, Gleason-Guzman M, Hurley LH (2003) Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes. J Med Chem 46:571–583
Permana PA, Snapka RM, Shen LL, Chu DTW, Clement JJ, Plattner JJ (1994) Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors. Biochemistry 33:11333–11339
Pottumarthy S (2006) Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes. Diagn Microbiol Infect Dis 54(2):127–134
Saito H (1994) In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a. Antimicrob Agents Chemother 38(12):2877–2882
Shammas MA, Shmookler Reis MA, Akiyama M, Koley H, Chauhan D, Hideshima T, Goyal RK, Hurley LH, Anderson KC, Munshi NC (2003) Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. Mol Cancer Ther 2:825–833
Vacher S (1999) Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin. J Antimicrob Chemother 44(5):647–652
Wang X (2002) Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative K-37. Mol Pharmacol 61(6):1359–1365
Witvrouw M (1998) Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12. Antivir Chem Chemother 9(5):403–411
Zhao YL (2005) Synthesis and antimycobacterial evaluation of certain fluoroquinolone derivatives. Bioorg Med Chem 13(12):3921–3926
Acknowledgement
The author (M. Shaharyar) thanks the University Grant Commission-New Delhi, India for a research award, Janab Abdul Mueed for providing the necessary facility, and Dr. Kiran Smith, National Cancer Institute-USA, for valuable suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shaharyar, M., Ali, M.A. & Abdullah, M.M. Synthesis and antiproliferative activity of 1-[(sub)]-6-fluoro-3-[(sub)]-1, 3,4-oxadiazol-2-yl-7-piperazino-1, 4-dihydro-4-quinolinone derivatives. Med Chem Res 16, 292–299 (2007). https://doi.org/10.1007/s00044-007-9031-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-007-9031-x